SII Working With US Firm To Launch Omicron-Specific Covid Vaccine After Six Months: Poonawalla

Adar Poonwalla, the Chief Executive Officer (CEO) of the Serum Institute of India (SII), said Thursday…

India’s first indigenously developed vaccine against cervical cancer to be launched tomorrow

Image Source : PTI/REPRESENTATIVE India’s first vaccine against cervical cancer to come on September 1 Highlights…

CEO Adar Poonawalla Says SII Conducting Research to Find Monkeypox Vaccine

Serum Institute of India CEO Adar Poonawalla Tuesday said his firm is conducting research to find…

SII Seeks Nod to Export 32.4 Lakh Doses of Its Covid Vaccine Covovax to US

The Drugs Controller General of India (DCGI) had granted permission in March for conducting Phase-3 clinical…

Serum Institute’s Covovax gets DCGI’s nod for emergency use in children aged 7-11 years

Image Source : FILE PHOTO Representational image. Highlights DCGI had approved Covovax for restricted use in…

DCGI Approves Serum Institute’s Covovax Covid Vaccine For 7-11 Age Group: Report

The Drugs Controller General of India (DCGI) on Tuesday approved Serum Institute of India’s Covovax Covid-19…

Govt panel recommends emergency approval of SII’s Covovax for 7-11 year-olds

New Delhi: The Subject Expert Committee (SEC) on Covid-19, an expert panel of India’s central drug…

Breaking News, June 16 | LIVE UPDATES

Image Source : INDIA TV. Breaking News, June 16 | LIVE UPDATES. Hello and welcome to…

Govt Panel Gives Nod To Serum Institute’s qHPV Vaccine For Cervical Cancer Patients Aged 9-26 Y

The Drugs Controller General of India’s (DCGI) Subject Expert Committee (SEC) has recommended the quadrivalent human…

SII Seeks from DCGI Market Authorisation for India’s First QHPV Vaccine Against Cervical Cancer

SII said the vaccine CERVAVAC has demonstrated robust antibody response that is nearly 1000 times higher…